Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Non Operating Income (2023)

Mereo BioPharma (MREO) has disclosed Non Operating Income for 1 consecutive years, with -$4000.0 as the latest value for Q4 2023.

  • Quarterly Non Operating Income changed N/A to -$4000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$4000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $300000.0 for FY2025, N/A changed from the prior year.
  • Non Operating Income for Q4 2023 was -$4000.0 at Mereo BioPharma, up from -$6000.0 in the prior quarter.
  • The five-year high for Non Operating Income was -$4000.0 in Q4 2023, with the low at -$6000.0 in Q1 2023.